Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff

Keytruda Towers At Top Of League

 
• By Eleanor Malone
Keytruda revenues grew as COVID-19 sales plummeted • Source: Shutterstock

More from Earnings

More from Business